有色人种皮肤使用防晒霜进行光保护:文献综述。

IF 1.5 4区 医学 Q3 DERMATOLOGY
Valerie D Callender, Lisa R Ginn, Charles M Boyd, Mona Gohara, Corey L Hartman, Valerie M Harvey, Tanya T Khan, William Kwan, Wendy E Roberts
{"title":"有色人种皮肤使用防晒霜进行光保护:文献综述。","authors":"Valerie D Callender, Lisa R Ginn, Charles M Boyd, Mona Gohara, Corey L Hartman, Valerie M Harvey, Tanya T Khan, William Kwan, Wendy E Roberts","doi":"10.36849/JDD.8250","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To understand the prevalence and types of publications addressing darker skin types within the existing evidence base for sunscreen use.&nbsp; Evidence Review: PubMed was searched from 1988, the time point at which the first skin of color (SOC) article was identified, through December 2022 using PubMed's Medical Subject Headings terms and keyword searches in title and abstract, with and without terms for SOC and ethnicity. Identified articles were reviewed for relevance, de-duplicated, and categorized; results are summarized.</p><p><strong>Findings: </strong>Of the 5927 articles on sunscreen overall, only 314 (5.3%) articles addressed SOC, with the majority published since 2007 and representing only 4% to 7% of total publications annually except in 2022 when the proportion of SOC articles was 23.5%. Of the articles on SOC, many reported sunscreen knowledge and patient behaviors (29%), but very few reported clinical trials (5%). The 3 conditions most often discussed were melasma, post-inflammatory hyperpigmentation, and dyschromia. South Asian ethnicities (India, Pakistan, Bangladesh) had the highest representation within the literature, followed by Hispanics.</p><p><strong>Conclusions and relevance: </strong>Although it was assumed there would be fewer papers discussing the use of sunscreen in darker skin types, the scale of the disparity revealed by this study is stark. The increase in a number of articles in 2022 suggests an increasing focus on SOC, but further discussion of the issues presented here will help the SOC community address gaps in the evidence base and better inform discussions on sunscreen and photoprotection between clinicians and patients.J Drugs Dermatol. 2024;23(7):575-577.&nbsp; doi:10.36849/JDD.8250.</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sunscreen Use for Photoprotection in Skin of Color: A Literature Review.\",\"authors\":\"Valerie D Callender, Lisa R Ginn, Charles M Boyd, Mona Gohara, Corey L Hartman, Valerie M Harvey, Tanya T Khan, William Kwan, Wendy E Roberts\",\"doi\":\"10.36849/JDD.8250\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>To understand the prevalence and types of publications addressing darker skin types within the existing evidence base for sunscreen use.&nbsp; Evidence Review: PubMed was searched from 1988, the time point at which the first skin of color (SOC) article was identified, through December 2022 using PubMed's Medical Subject Headings terms and keyword searches in title and abstract, with and without terms for SOC and ethnicity. Identified articles were reviewed for relevance, de-duplicated, and categorized; results are summarized.</p><p><strong>Findings: </strong>Of the 5927 articles on sunscreen overall, only 314 (5.3%) articles addressed SOC, with the majority published since 2007 and representing only 4% to 7% of total publications annually except in 2022 when the proportion of SOC articles was 23.5%. Of the articles on SOC, many reported sunscreen knowledge and patient behaviors (29%), but very few reported clinical trials (5%). The 3 conditions most often discussed were melasma, post-inflammatory hyperpigmentation, and dyschromia. South Asian ethnicities (India, Pakistan, Bangladesh) had the highest representation within the literature, followed by Hispanics.</p><p><strong>Conclusions and relevance: </strong>Although it was assumed there would be fewer papers discussing the use of sunscreen in darker skin types, the scale of the disparity revealed by this study is stark. The increase in a number of articles in 2022 suggests an increasing focus on SOC, but further discussion of the issues presented here will help the SOC community address gaps in the evidence base and better inform discussions on sunscreen and photoprotection between clinicians and patients.J Drugs Dermatol. 2024;23(7):575-577.&nbsp; doi:10.36849/JDD.8250.</p>\",\"PeriodicalId\":15566,\"journal\":{\"name\":\"Journal of Drugs in Dermatology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Drugs in Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.36849/JDD.8250\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.8250","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:了解现有防晒霜使用证据库中涉及深色皮肤类型的出版物的流行程度和类型:使用 PubMed 医学主题词表以及标题和摘要中的关键字搜索,使用或不使用 SOC 和种族术语,搜索了从 1988 年(第一篇肤色 (SOC) 文章被识别的时间点)到 2022 年 12 月的 PubMed。对确定的文章进行了相关性审查、去重和分类,并对结果进行了总结:在 5927 篇关于防晒霜的文章中,只有 314 篇(5.3%)涉及到了 SOC,其中大部分文章发表于 2007 年以后,每年只占总发表量的 4% 到 7%,2022 年除外,当时 SOC 文章的比例为 23.5%。在有关 SOC 的文章中,许多文章报道了防晒知识和患者行为(29%),但报道临床试验的文章很少(5%)。讨论最多的三种情况是黄褐斑、炎症后色素沉着和色素沉着。南亚族裔(印度、巴基斯坦、孟加拉国)在文献中的代表性最高,其次是西班牙裔:尽管我们认为讨论深肤色皮肤使用防晒霜的论文会比较少,但本研究揭示的差距规模却非常明显。2022年文章数量的增加表明人们越来越关注SOC,但进一步讨论这里提出的问题将有助于SOC社区解决证据基础中的差距,并为临床医生和患者之间关于防晒和光保护的讨论提供更好的信息。2024;23(7):575-577.  doi:10.36849/JDD.8250.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Sunscreen Use for Photoprotection in Skin of Color: A Literature Review.

Background: To understand the prevalence and types of publications addressing darker skin types within the existing evidence base for sunscreen use.  Evidence Review: PubMed was searched from 1988, the time point at which the first skin of color (SOC) article was identified, through December 2022 using PubMed's Medical Subject Headings terms and keyword searches in title and abstract, with and without terms for SOC and ethnicity. Identified articles were reviewed for relevance, de-duplicated, and categorized; results are summarized.

Findings: Of the 5927 articles on sunscreen overall, only 314 (5.3%) articles addressed SOC, with the majority published since 2007 and representing only 4% to 7% of total publications annually except in 2022 when the proportion of SOC articles was 23.5%. Of the articles on SOC, many reported sunscreen knowledge and patient behaviors (29%), but very few reported clinical trials (5%). The 3 conditions most often discussed were melasma, post-inflammatory hyperpigmentation, and dyschromia. South Asian ethnicities (India, Pakistan, Bangladesh) had the highest representation within the literature, followed by Hispanics.

Conclusions and relevance: Although it was assumed there would be fewer papers discussing the use of sunscreen in darker skin types, the scale of the disparity revealed by this study is stark. The increase in a number of articles in 2022 suggests an increasing focus on SOC, but further discussion of the issues presented here will help the SOC community address gaps in the evidence base and better inform discussions on sunscreen and photoprotection between clinicians and patients.J Drugs Dermatol. 2024;23(7):575-577.  doi:10.36849/JDD.8250.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.20
自引率
13.30%
发文量
289
审稿时长
3-6 weeks
期刊介绍: The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信